🇺🇸 MRK — Merck & Co., Inc.
Healthcare CompraPrecio actual
150,33 USD
Máx. histórico
156,92
10 días
Split 1048:1000 del 03/06/2021
Caída desde máximo
-4,20%
Rango 52 semanas
77,58 – 156,92
Variación hoy
-1,32%
Cierre anterior
152,34
Rango de hoy
150,09 – 152,22
Volumen hoy
4.298.143
- Nombre completo
- Merck & Co., Inc.
- Divisa
- USD
- Mercado
- NYSE
- Sector
- Healthcare
- Industria
- Drug Manufacturers - General
- Empleados
- 73.000
- PER ⓘ
- 120,26 (puede no estar actualizado)
- Dividend yield
- 2,23% (puede no estar actualizado)
- Precio objetivo analistas
- 149,50 USD (puede no estar actualizado)
- Primera cotización
- 02/01/1962
- Precio actualizado
- hace 3 días
Merck & Co., Inc. operates as a healthcare company worldwide. It offers human health pharmaceutical for various areas under the Keytruda, Keytruda Qlex, Welireg, Gardasil, ProQuad, M-M-R II, Varivax, Vaxneuvance, Capvaxive, RotaTeq, Pneumovax 23, Bridion, Prevymis, Dificid, Zerbaxa, Winrevair, Adempas/ Verquvo, Ohtuvayre, Lagevrio, Isentress/Isentress HD, Delstrigo, Pifeltro, Belsomra, Januvia, and Janumet brands. The company also provides veterinary pharmaceuticals, vaccines and health management solutions and services, such as livestock products under the Nuflor, Bovilis/Vista, Bovilis Cryptium, Banamine, Estrumate, Matrix, Resflor, Zuprevo, Revalor, Safe-Guard, M+Pac, Porcilis, Circumvent, Nobilis/Innovax, Paracox and Coccivac, Exzolt, Slice, Imvixa, Clynav, Aquavac/Norvax, Aquaflor, Flexolt brands; Allflex Livestock Intelligence solutions; and companion animal products under the Bravecto One-Month, Bravecto Injectable/Quantum, Bravecto TriUNO, Bravecto Plus, Sentinel Spectrum, Sentinel Flavor Tabs, Numelvi, Optimmune, Nobivac NXT, GilvetMab, Otomax, Mometamax, Mometamax Ultra, Posatex, Caninsulin/Vetsulin, Panacur, Safeguard, Regumate, Prestige, Scalibor/Exspot, Sure Petcare, and Home Again brands. It has development and commercialization agreement for three of Daiichi Sankyo's deruxtecan ADC candidates; AstraZeneca PLC to co-development and co-commercialize AstraZeneca's Lynparza products for multiple cancer types; licensed to develop, manufacture and commercialize LM-299, a novel investigational PD-1/VEGF bispecific antibody from LaNova; and collaboration agreement with Eisai Co., Ltd., Bayer AG, and Ridgeback Biotherapeutics LP, as well Moderna, Inc. Merck & Co., Inc. has strategic collaboration with Infinimmune, Inc. to discover and develop antibodies against multiple therapeutic targets. The company was founded in 1891 and is headquartered in Rahway, New Jersey.
| Fecha de pago | Importe por participación |
|---|---|
| 03/12/1973 | 0,0093 USD |
| 31/08/1973 | 0,0078 USD |
| 05/06/1973 | 0,0078 USD |
| 05/03/1973 | 0,0078 USD |
| 05/12/1972 | 0,0078 USD |
| 09/06/1972 | 0,0073 USD |
| 02/03/1972 | 0,0073 USD |
| 06/12/1971 | 0,0073 USD |
| 03/09/1971 | 0,0073 USD |
| 07/06/1971 | 0,0073 USD |
| 02/03/1971 | 0,0073 USD |
| 01/12/1970 | 0,0073 USD |
| 02/09/1970 | 0,0066 USD |
| 02/06/1970 | 0,0066 USD |
| Fecha | Ratio |
|---|---|
| 03/06/2021 | 1048:1000 |
| 17/02/1999 | 2:1 |
| 26/05/1992 | 3:1 |
| 26/05/1988 | 3:1 |
| 27/05/1986 | 2:1 |
| 01/06/1972 | 2:1 |
| Fecha | Apertura | Máximo | Mínimo | Cierre | Variación | Volatilidad día | Volumen |
|---|---|---|---|---|---|---|---|
| 30/10/1985 | 3,04 | 3,07 | 3,03 | 3,07 | +1,76% | 1,20% | 8.217.158 |
| 29/10/1985 | 2,98 | 3,02 | 2,97 | 3,02 | +1,56% | 1,78% | 4.595.270 |
| 28/10/1985 | 2,97 | 2,98 | 2,96 | 2,97 | -0,11% | 0,67% | 2.678.688 |
| 25/10/1985 | 2,98 | 2,99 | 2,97 | 2,97 | -0,34% | 0,45% | 2.014.675 |
| 24/10/1985 | 3,00 | 3,00 | 2,98 | 2,98 | -0,44% | 0,77% | 6.379.805 |
| 23/10/1985 | 3,00 | 3,00 | 2,98 | 3,00 | -0,22% | 0,44% | 5.255.510 |
| 22/10/1985 | 2,99 | 3,01 | 2,98 | 3,00 | +0,55% | 1,11% | 5.406.422 |
| 21/10/1985 | 3,01 | 3,02 | 2,99 | 2,99 | -0,99% | 0,99% | 2.286.317 |
| 18/10/1985 | 3,02 | 3,03 | 3,00 | 3,02 | -0,22% | 0,99% | 10.228.061 |
| 17/10/1985 | 3,00 | 3,03 | 2,99 | 3,02 | +0,88% | 1,55% | 14.495.098 |
| 16/10/1985 | 2,91 | 3,00 | 2,90 | 3,00 | +3,08% | 3,19% | 12.499.286 |
| 15/10/1985 | 2,90 | 2,91 | 2,88 | 2,91 | +0,00% | 0,91% | 3.414.384 |
| 14/10/1985 | 2,90 | 2,91 | 2,90 | 2,91 | +0,11% | 0,46% | 1.867.536 |
| 11/10/1985 | 2,89 | 2,90 | 2,89 | 2,90 | +0,81% | 0,58% | 4.097.261 |
| 10/10/1985 | 2,88 | 2,89 | 2,87 | 2,88 | -0,34% | 0,69% | 2.761.690 |
| 09/10/1985 | 2,89 | 2,91 | 2,89 | 2,89 | -0,68% | 0,69% | 4.263.264 |
| 08/10/1985 | 2,87 | 2,91 | 2,86 | 2,91 | +1,39% | 1,62% | 5.738.429 |
| 07/10/1985 | 2,84 | 2,89 | 2,82 | 2,87 | +1,53% | 2,45% | 8.036.064 |
| 04/10/1985 | 2,82 | 2,83 | 2,81 | 2,83 | +0,12% | 0,59% | 3.006.922 |
| 03/10/1985 | 2,83 | 2,84 | 2,81 | 2,82 | -0,47% | 1,17% | 10.024.330 |
| 02/10/1985 | 2,89 | 2,89 | 2,84 | 2,84 | -1,61% | 1,95% | 10.650.614 |
| 01/10/1985 | 2,87 | 2,89 | 2,85 | 2,88 | +0,46% | 1,50% | 6.772.176 |
| 30/09/1985 | 2,88 | 2,89 | 2,86 | 2,87 | -0,58% | 0,92% | 4.625.453 |
| 26/09/1985 | 2,86 | 2,89 | 2,86 | 2,89 | +0,69% | 0,81% | 5.553.562 |
| 25/09/1985 | 2,90 | 2,90 | 2,86 | 2,87 | -1,26% | 1,37% | 10.726.070 |
| 24/09/1985 | 2,90 | 2,94 | 2,90 | 2,90 | +0,23% | 1,37% | 9.643.277 |
| 23/09/1985 | 2,90 | 2,91 | 2,89 | 2,90 | +1,16% | 0,69% | 9.643.277 |
| 20/09/1985 | 2,87 | 2,89 | 2,86 | 2,86 | -0,58% | 1,04% | 7.937.971 |
| 19/09/1985 | 2,85 | 2,89 | 2,85 | 2,88 | +0,70% | 1,40% | 10.186.560 |
| 18/09/1985 | 2,92 | 2,92 | 2,74 | 2,86 | -2,60% | 6,12% | 42.481.728 |